Free Trial

BioVie (BIVIW) Competitors

BioVie logo
$0.28 0.00 (0.00%)
As of 09:44 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BIVIW vs. ALVOW, APLMW, ARAV, BIAFW, and CDIOW

Should you buy BioVie stock or one of its competitors? BioVie's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does BioVie compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, Alvotech had 3 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for BioVie. Alvotech's average media sentiment score of 0.70 beat BioVie's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Alvotech beats BioVie on 3 of the 3 factors compared between the two stocks.

How does BioVie compare to Apollomics?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
BioVie N/A N/A N/A

Summary

Apollomics beats BioVie on 1 of the 1 factors compared between the two stocks.

How does BioVie compare to Aravive?

Aravive (NASDAQ:ARAV) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
BioVieN/AN/AN/AN/AN/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
BioVie Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Aravive beats BioVie on 2 of the 2 factors compared between the two stocks.

How does BioVie compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for BioVie. BioVie's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.78 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Negative
BioVie Neutral

Summary

bioAffinity Technologies beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Cardio Diagnostics Neutral

Summary

Cardio Diagnostics beats BioVie on 1 of the 1 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIVIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVIW vs. The Competition

MetricBioVieBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.88B$7.19B$13.38B
Dividend YieldN/A3.65%2.53%17.39%
P/E RatioN/A13.29273.9426.49
Price / SalesN/A1,239.12640.04108.72
Price / CashN/A126.5679.4153.24
Price / BookN/A16.1510.836.33
Net IncomeN/A-$22.65M$3.50B$381.96M
7 Day Performance-12.50%-4.16%-2.11%-0.41%
1 Month Performance-21.79%-12.16%-7.10%-4.85%
1 Year PerformanceN/A13.72%5.78%1.42%

BioVie Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVIW
BioVie
N/A$0.28
flat
N/AN/A$0.00N/AN/A13
ALVOW
Alvotech
N/A$0.26
-1.8%
N/A-65.7%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
-21.6%
N/A-45.0%$0.00$8.50MN/A15
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.40
+25.9%
N/A+70.4%$0.00$5.85MN/A10

Related Companies and Tools


This page (NASDAQ:BIVIW) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners